Do Premenopausal Hypothyroid Women on Levothyroxine Therapy Need Bone Status Monitoring?

BACKGROUND: Suppressive doses of levothyroxine therapy are reported to reduce bone mineral density (BMD) in women. Data on bone changes in premenopausal hypothyroid women with replacement therapy are limited. Hence, this study was undertaken to evaluate bone changes in this group using bone markers...

Descripción completa

Detalles Bibliográficos
Autores principales: Babu, Ruby P, Christy, Alap, Hegde, Anupama, Manjrekar, Poornima, D’Souza, Vivian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362625/
https://www.ncbi.nlm.nih.gov/pubmed/25861238
http://dx.doi.org/10.4137/CMWH.S22114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362625/
https://www.ncbi.nlm.nih.gov/pubmed/25861238
http://dx.doi.org/10.4137/CMWH.S22114

Ejemplares similares